Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/917520/000119312512081503/d261286d10k.htm
Exhibit 99.1
News Release
Contacts:
Integra LifeSciences Holdings Corporation |
||
John B. Henneman, III | Investor Relations: | |
Executive Vice President, Chief Financial Officer |
Angela Steinway | |
(609) 275-0500 |
(609) 936-2268 | |
jack.henneman@integralife.com |
angela.steinway@integralife.com |
Integra LifeSciences Reports Fourth Quarter and Full-Year 2011 Financial Results
Results In Line with Preliminary Announcement
Provides 2012 Guidance
Plainsboro, New Jersey, February 23, 2012 Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the fourth quarter and full year ending December 31, 2011. Total revenues for the fourth quarter were $203.5 million, reflecting an increase of $9.4 million, or 5%, over the fourth quarter of 2010. Total revenues in the full year of 2011 were $780.1 million, reflecting an increase of $48 million, or 7%, over the full year of 2010. Excluding the impact of currency exchange rates, revenues increased 5% over the fourth quarter of 2010 and 5% over the full year 2010. We present revenues by product category in a table at the end of this press release.
The Company reported GAAP net income of $4.6 million, or $0.16 per diluted share, for the fourth quarter of 2011, compared to GAAP net income of $18.8 million, or $0.63 per diluted share, for the fourth quarter of 2010. The Company reported GAAP net income of $28.0 million, or $0.95 per diluted share, for the full year 2011, compared to GAAP net income of $65.7 million, or $2.17 per diluted share in 2010.
Adjusted net income for the fourth quarter of 2011, computed with the adjustments to GAAP reporting set forth in the attached reconciliation, was $20.6 million, or $0.72 per diluted share, compared to $24.0 million, or $0.80 per diluted share, in the fourth quarter of 2010. Adjusted net income for the full year 2011, computed with the adjustments to GAAP reporting set forth in the attached reconciliation, was $82.2 million, or $2.79 per diluted share, compared to $89.9 million, or $2.97 per diluted share in 2010.
Integra generated $34.7 million in cash flows from operations and used $13 million of cash on capital expenditures in the fourth quarter of 2011. For the full year ended December 31, 2011, Integras cash flows from operations totaled $104.3 million. The Company used $38.4 million of cash on capital expenditures during the year.
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Integra Lifesciences Holdings Corp.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/917520/000119312512081503/d261286d10k.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years